Vimarsana
Biggest News Aggregation in the World

Page 25 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Direct-to-Consumer Genetic Testing Market Worth $7.19 - Vimarsana News

Direct-to-Consumer Genetic Testing Market Worth $7.19

The direct-to-consumer genetic testing market is growing at a CAGR of 19.6% from 2022 to 2030....

Prostate Cancer Antigen 3 (PCA3) Test Market Size to Surpass USD 7.64 Billion by 2029 - Vimarsana News

Prostate Cancer Antigen 3 (PCA3) Test Market Size to Surpass USD 7.64 Billion by 2029

Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the Prostate Cancer Antigen 3 (PCA3) Test Market. The newly published report employs an appealing layout that presents essential data using visually engaging tables, graphs, charts, and figures.The Prostate Cancer Antigen...

Global and Regional Rare Disease Genetic Testing Market Report 2023-2033: Early Detection Demand and Innovative Systems Usher in New Era for Rare Disease Genetic Testing - Vimarsana News

Global and Regional Rare Disease Genetic Testing Market Report 2023-2033: Early Detection Demand and Innovative Systems Usher in New Era for Rare Disease Genetic Testing

/PRNewswire/ -- The "Rare Disease Genetic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Offering, Specialty Type, Sample Type, Trait...

Myriad Genetics (NASDAQ:MYGN) Stock Price Down 4% - Vimarsana News

Myriad Genetics (NASDAQ:MYGN) Stock Price Down 4%

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) was down 4% during mid-day trading on Friday . The company traded as low as $15.99 and last traded at $16.12. Approximately 265,475 shares changed hands during trading, a decline of 53% from the average daily volume of 562,167 shares. The stock had previously closed at $16.79. […]

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood - Vimarsana News

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

SALT LAKE CITY, Sept. 28, 2023 -- Myriad Genetics, Inc. , a leader in genetic testing and precision medicine, today announced results from a nationwide survey revealing breast density and family...